UniProt ID | AGO2_MOUSE | |
---|---|---|
UniProt AC | Q8CJG0 | |
Protein Name | Protein argonaute-2 {ECO:0000255|HAMAP-Rule:MF_03031} | |
Gene Name | Ago2 | |
Organism | Mus musculus (Mouse). | |
Sequence Length | 860 | |
Subcellular Localization | Cytoplasm, P-body . Nucleus . Translational repression of mRNAs results in their recruitment to P-bodies. Translocation to the nucleus requires IMP8. | |
Protein Description | Required for RNA-mediated gene silencing (RNAi) by the RNA-induced silencing complex (RISC). The 'minimal RISC' appears to include AGO2 bound to a short guide RNA such as a microRNA (miRNA) or short interfering RNA (siRNA). These guide RNAs direct RISC to complementary mRNAs that are targets for RISC-mediated gene silencing. The precise mechanism of gene silencing depends on the degree of complementarity between the miRNA or siRNA and its target. Binding of RISC to a perfectly complementary mRNA generally results in silencing due to endonucleolytic cleavage of the mRNA specifically by AGO2. Binding of RISC to a partially complementary mRNA results in silencing through inhibition of translation, and this is independent of endonuclease activity. May inhibit translation initiation by binding to the 7-methylguanosine cap, thereby preventing the recruitment of the translation initiation factor eIF4-E. May also inhibit translation initiation via interaction with EIF6, which itself binds to the 60S ribosomal subunit and prevents its association with the 40S ribosomal subunit. The inhibition of translational initiation leads to the accumulation of the affected mRNA in cytoplasmic processing bodies (P-bodies), where mRNA degradation may subsequently occur. In some cases RISC-mediated translational repression is also observed for miRNAs that perfectly match the 3' untranslated region (3'-UTR). Can also up-regulate the translation of specific mRNAs under certain growth conditions. Binds to the AU element of the 3'-UTR of the TNF (TNF-alpha) mRNA and up-regulates translation under conditions of serum starvation. Also required for transcriptional gene silencing (TGS), in which short RNAs known as antigene RNAs or agRNAs direct the transcriptional repression of complementary promoter regions. Regulates lymphoid and erythroid development and function, and this is independent of endonuclease activity.. | |
Protein Sequence | MYSGAGPVLASPAPTTSPIPGYAFKPPPRPDFGTTGRTIKLQANFFEMDIPKIDIYHYELDIKPEKCPRRVNREIVEHMVQHFKTQIFGDRKPVFDGRKNLYTAMPLPIGRDKVELEVTLPGEGKDRIFKVSIKWVSCVSLQALHDALSGRLPSVPFETIQALDVVMRHLPSMRYTPVGRSFFTASEGCSNPLGGGREVWFGFHQSVRPSLWKMMLNIDVSATAFYKAQPVIEFVCEVLDFKSIEEQQKPLTDSQRVKFTKEIKGLKVEITHCGQMKRKYRVCNVTRRPASHQTFPLQQESGQTVECTVAQYFKDRHKLVLRYPHLPCLQVGQEQKHTYLPLEVCNIVAGQRCIKKLTDNQTSTMIRATARSAPDRQEEISKLMRSASFNTDPYVREFGIMVKDEMTDVTGRVLQPPSILYGGRNKAIATPVQGVWDMRNKQFHTGIEIKVWAIACFAPQRQCTEVHLKSFTEQLRKISRDAGMPIQGQPCFCKYAQGADSVEPMFRHLKNTYAGLQLVVVILPGKTPVYAEVKRVGDTVLGMATQCVQMKNVQRTTPQTLSNLCLKINVKLGGVNNILLPQGRPPVFQQPVIFLGADVTHPPAGDGKKPSIAAVVGSMDAHPNRYCATVRVQQHRQEIIQDLAAMVRELLIQFYKSTRFKPTRIIFYRDGVSEGQFQQVLHHELLAIREACIKLEKDYQPGITFIVVQKRHHTRLFCTDKNERVGKSGNIPAGTTVDTKITHPTEFDFYLCSHAGIQGTSRPSHYHVLWDDNRFSSDELQILTYQLCHTYVRCTRSVSIPAPAYYAHLVAFRARYHLVDKEHDSAEGSHTSGQSNGRDHQALAKAVQVHQDTLRTMYFA | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Nitration | ------MYSGAGPVL ------CCCCCCCEE | 18.80 | 16800626 | |
2 | Nitration | ------MYSGAGPVL ------CCCCCCCEE | 18.80 | 16800626 | |
2 | Nitrated tyrosine | ------MYSGAGPVL ------CCCCCCCEE | 18.80 | - | |
11 | Phosphorylation | GAGPVLASPAPTTSP CCCCEECCCCCCCCC | 19.89 | 26824392 | |
15 | Phosphorylation | VLASPAPTTSPIPGY EECCCCCCCCCCCCC | 41.85 | 26239621 | |
16 | Phosphorylation | LASPAPTTSPIPGYA ECCCCCCCCCCCCCC | 31.29 | 26239621 | |
17 | Phosphorylation | ASPAPTTSPIPGYAF CCCCCCCCCCCCCCC | 24.26 | 26239621 | |
22 | Phosphorylation | TTSPIPGYAFKPPPR CCCCCCCCCCCCCCC | 11.96 | 26643407 | |
34 | Phosphorylation | PPRPDFGTTGRTIKL CCCCCCCCCCCEEEE | 26.52 | 26643407 | |
35 | Phosphorylation | PRPDFGTTGRTIKLQ CCCCCCCCCCEEEEE | 25.66 | 26643407 | |
154 | Phosphorylation | ALSGRLPSVPFETIQ HHCCCCCCCCHHHHH | 47.19 | 46103327 | |
159 | Phosphorylation | LPSVPFETIQALDVV CCCCCHHHHHHHHHH | 20.83 | 51458725 | |
172 | Phosphorylation | VVMRHLPSMRYTPVG HHHHHCCCCCEECCC | 23.42 | 51458731 | |
249 | Ubiquitination | KSIEEQQKPLTDSQR CCHHHHCCCCCHHHH | 41.51 | 22790023 | |
254 | Phosphorylation | QQKPLTDSQRVKFTK HCCCCCHHHHHHHHH | 18.04 | 28464351 | |
256 | Dimethylation | KPLTDSQRVKFTKEI CCCCHHHHHHHHHHH | 37.23 | - | |
386 | Phosphorylation | EISKLMRSASFNTDP HHHHHHHHHCCCCCH | 17.82 | 23527152 | |
388 | Phosphorylation | SKLMRSASFNTDPYV HHHHHHHCCCCCHHH | 21.92 | 23527152 | |
391 | Phosphorylation | MRSASFNTDPYVREF HHHHCCCCCHHHHHH | 36.02 | 28833060 | |
394 | Phosphorylation | ASFNTDPYVREFGIM HCCCCCHHHHHHCEE | 18.23 | 28833060 | |
426 | Ubiquitination | ILYGGRNKAIATPVQ EEECCCCCCCCCCCC | 39.55 | 22790023 | |
470 | Phosphorylation | CTEVHLKSFTEQLRK CCHHHHHHHHHHHHH | 43.70 | 23970565 | |
626 | Phosphorylation | MDAHPNRYCATVRVQ CCCCCCCEEEEEEHH | 7.96 | 22345495 | |
629 | Phosphorylation | HPNRYCATVRVQQHR CCCCEEEEEEHHHHH | 12.80 | 22345495 | |
655 | Phosphorylation | RELLIQFYKSTRFKP HHHHHHHHHHCCCCC | 6.40 | - | |
701 | Hydroxylation | KLEKDYQPGITFIVV HHHHCCCCCEEEEEE | 29.89 | - | |
721 | Ubiquitination | TRLFCTDKNERVGKS EEEEECCCCCCCCCC | 42.42 | 22790023 | |
727 | Ubiquitination | DKNERVGKSGNIPAG CCCCCCCCCCCCCCC | 52.94 | 22790023 | |
816 | Phosphorylation | LVAFRARYHLVDKEH HHHHHHHEEECCCCC | 9.87 | 25777480 | |
825 | Phosphorylation | LVDKEHDSAEGSHTS ECCCCCCCCCCCCCC | 30.08 | 27087446 | |
829 | Phosphorylation | EHDSAEGSHTSGQSN CCCCCCCCCCCCCCC | 18.33 | 27087446 | |
831 | Phosphorylation | DSAEGSHTSGQSNGR CCCCCCCCCCCCCCC | 35.93 | 22817900 | |
832 | Phosphorylation | SAEGSHTSGQSNGRD CCCCCCCCCCCCCCC | 29.43 | 22817900 | |
835 | Phosphorylation | GSHTSGQSNGRDHQA CCCCCCCCCCCCHHH | 44.79 | 25777480 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of AGO2_MOUSE !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of AGO2_MOUSE !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of AGO2_MOUSE !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
DICER_HUMAN | DICER1 | physical | 12526743 | |
LIN41_MOUSE | Trim71 | physical | 19898466 |
Kegg Drug | ||||||
---|---|---|---|---|---|---|
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Nitration | |
Reference | PubMed |
"Endogenously nitrated proteins in mouse brain: links toneurodegenerative disease."; Sacksteder C.A., Qian W.-J., Knyushko T.V., Wang H., Chin M.H.,Lacan G., Melega W.P., Camp D.G. II, Smith R.D., Smith D.J.,Squier T.C., Bigelow D.J.; Biochemistry 45:8009-8022(2006). Cited for: NITRATION [LARGE SCALE ANALYSIS] AT TYR-2, AND MASS SPECTROMETRY. |